01/13/2025
4:27 PM | Intra-Cellular Therapies (Filer)
| Form DEFA14A | |
01/13/2025
4:27 PM | Intra-Cellular Therapies (Subject)
JOHNSON & JOHNSON (Filed by)
| Form DFAN14A | |
01/13/2025
6:47 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
6:48 AM | Intra-Cellular Therapies (Filer)
| Form DEFA14A | |
01/10/2025
5:46 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:27 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
6:38 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:01 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/30/2024
6:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
6:53 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Intra-Cellular Therapies (Subject)
| Form SC 13G/A | |
10/15/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
11:36 AM | Intra-Cellular Therapies (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G | |
10/02/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
4:43 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:06 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:34 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:34 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:36 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:09 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
5:03 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
Narula Sanjeev (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
Narula Sanjeev (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
6:55 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:49 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
7:00 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:00 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:04 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:05 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:05 PM | Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:05 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:28 PM | Intra-Cellular Therapies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/21/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
I was wrong. Dead wrong. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
06/18/2024
5:02 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
5:02 PM | Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
6:37 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:40 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:43 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
3:46 PM | Intra-Cellular Therapies (Filer)
| Form DEFA14A | |
04/29/2024
3:48 PM | Intra-Cellular Therapies (Filer)
| Form ARS | |
04/24/2024
3:20 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
4:23 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/18/2024
4:25 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:40 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:37 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/16/2024
6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:15 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
4:15 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:31 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:31 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:32 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:33 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:33 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:52 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:38 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:45 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:30 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:30 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
4:58 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:58 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:58 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:59 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:59 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:44 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
3:36 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
3:27 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:04 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:05 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:05 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:05 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:41 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:57 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:58 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:58 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:59 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
7:00 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
7:00 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:22 PM | Intra-Cellular Therapies (Subject)
VAN NOSTRAND ROBERT L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:46 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:46 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:33 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Stunning Trump Manhattan Project Now Underway (Ad) Just as I predicted, President Trump announced his #1 move during his first 100 days...
His allies are calling it Trump’s Manhattan Project. You simply have to see this.. |
02/26/2024
3:22 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:42 AM | Intra-Cellular Therapies (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/09/2024
11:40 AM | Intra-Cellular Therapies (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024
5:02 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:05 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:07 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:10 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:13 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
